Access cutting-edge diabetes mellitus, type 1 treatment through this clinical trial at a research site in Sylmar. Study-provided care at no cost to qualified participants.
Quick Self-Assessment
See if you qualify for this Sylmar location
Preparing your pre-screening questions…
Access diabetes mellitus, type 1 specialists at no cost
This study follows strict safety protocols and ethical guidelines
All study-related diabetes mellitus, type 1 treatment provided free
Check if you qualify for this diabetes mellitus, type 1 clinical trial in Sylmar, CA
No-Cost Study Care
Local to Sylmar
Convenient for CA residents
Cutting-Edge Treatment
Access to innovative therapies
Expert Medical Care
Close monitoring by specialists
Possible Compensation*
For time and travel
*Compensation varies by study. Confirm details with coordinator.
Diabetes technology has revolutionized T1D management, disparities in technology access are evident among racial-ethnic minorities, patients with lower socioeconomic status and those with poorly controlled T1D (A1c\>8.5%). In order to examine whether diabetes technology can reduce diabetes care burdens and enhance outcomes among some of highest need patients, diabetes technology clinical trials must be expanded beyond the very select populations included in studies thus far (ie., mostly White, higher SES). Therefore, the investigators propose to perform a pilot RCT of hybrid closed-loop insulin pump therapy (HCL) in 40 diverse adult patients with poorly controlled T1D (HbA1c \>8.5%) from the largest academic and safety net health systems in the Los Angeles region to determine the feasibility of a RCT in this population and identify facilitators and barriers of effective use of closed loop insulin pump therapy in patients with poorly controlled T1D.
Sponsor: University of California, Los Angeles
Yes, this clinical trial (NCT06453928) has an active research site in Sylmar, CA that is currently enrolling participants.
Clinical trials follow strict safety guidelines and ethical standards. This study has been reviewed and approved, and participants are closely monitored by medical professionals. You can withdraw at any time.
Many clinical trials offer compensation for your time and travel expenses. Specific compensation details will be discussed during the screening process. All study-related medical care is provided at no cost.
Absolutely. Participation is completely voluntary. You have the right to withdraw from the study at any time, for any reason, without penalty.
If you're searching for diabetes mellitus, type 1 treatment options in Sylmar, CA, this clinical trial (NCT06453928) may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.
Our Sylmar research site is actively enrolling participants for this clinical trial. You'll receive care from experienced diabetes mellitus, type 1 specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.
Looking for more options? Browse all diabetes mellitus, type 1 clinical trials near you to find additional studies recruiting in your area.
See all pulmonary embolism clinical trials recruiting in Sylmar — not just this study.
Browse Pulmonary Embolism Trials in Sylmar →